Search Results - ESCURIOLA-ETTINGHAUSEN, C.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates

    Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates by von AUER, CH, OLDENBURG, J., von DEPKA, M., ESCURIOLA-ETTINGHAUSEN, C., KURNIK, K., LENK, H., SCHARRER, I.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia

    Long‐term follow‐up of neonatal intracranial haemorrhage in children with severe haemophilia by Andersson, Nadine G., Wu, Runhui, Carcao, Manuel, Claeyssens‐Donadel, Ségolène, Kobelt, Rainer, Liesner, Ri, Mäkipernaa, Anne, Ranta, Susanna, Ljung, Rolf, Auerswald, G., Barnes, C., Chalmers, E., Chambost, H., Clausen, N., Dunn, A.L., Escuriola Ettinghausen, C., Fischer, K., Fijnvandraat, K., Geet, C., Hoffmann, M., Kavakli, K., Kenet, G., Königs, C., Kurnik, K., Manco‐Johnson, M., Mancuso, M.E., Molinari, C., Muntean, W., Nolan, B., Perez Garrido, R., Platokouki, E., Rafowicz, A., Santagostino, E., Shapiro, A., Thomas, A., Williams, M.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice

    Risk stratification for inhibitor development at first treatment for severe hemophilia A: a tool for clinical practice by TER AVEST, P. C., FISCHER, K., MANCUSO, M. E., SANTAGOSTINO, E., YUSTE, V. J., VAN DEN BERG, H. M., VAN DER BOM, J. G.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A

    Platelet-dependent coagulation assays for factor VIII efficacy measurement after substitution therapy in patients with haemophilia A by Bassus, S., Wegert, W., Krause, M., Escuriola-Ettinghausen, C., Siegemund, A., Petros, S., Scholz, T., Scharrer, I., Kreuz, W., Engelmann, L., Kirchmaier, C. M.

    Published in Platelets (Edinburgh)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    The Malmo International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A

    The Malmo International Brother Study (MIBS). Genetic defects and inhibitor development in siblings with severe hemophilia A by Astermark, J, Oldenburg, J, Escobar, M, White, GC, 2nd, Berntorp, E, Malmo International Brother Study study group

    Published in Haematologica (Roma)
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    F VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates

    F VIII Inhibitors in Haemophilia A Patients after Continuous Infusion of Factor VIII Concentrates by von Auer, Ch, Oldenburg, J., von Depka, M., Escuriola-Ettinghausen, C., Kreuz, W., Kurnik, K., Lenk, H., Varvenne, M., Scharrer, I.

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study

    Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study by Gouw, Samantha C., van der Bom, Johanna G., Auerswald, Günter, Ettinghausen, Carmen Escuriola, Tedgård, Ulf, van den Berg, H. Marijke

    Published in Blood
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. Commentary

    Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study. Commenta... by ABSHIRE, Thomas, GOUW, Samantha C, VAN DER BOM, Johanna G, AUERSWALD, Günter, ETTINGHAUSEN, Carmen Escuriola, TEDGARD, Ulf, VAN DEN BERG, H. Marijke

    Published in Blood
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: